Group One Trading’s Petros Pharmaceuticals PTPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4
Closed -$37K 8495
2021
Q1
$37K Buy
+4
New +$3.77K ﹤0.01% 6422

Group One Trading's PTPI Position: Q2 2025 in Review

Group One Trading sold out of Petros Pharmaceuticals (PTPI) in Q2 2025, closing a stake of 3 shares — an estimated $5 sold.

Group One Trading first reported a position in PTPI in Q2 2023 and held it in 8 quarters. The position peaked at $160 in Q2 2023. 0 funds tracked by Wall St. Rank hold PTPI as of Q2 2025.

  • Group One Trading reported no remaining Petros Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 3 Petros Pharmaceuticals shares in Q2 2025, an estimated $5.
  • Group One Trading first reported a position in Petros Pharmaceuticals in Q2 2023 and held it in 8 quarters.
  • Group One Trading's Petros Pharmaceuticals position peaked at $160 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.